Advertisement

Index by author

May 01, 2004; Volume 309,Issue 2

  1. Peterson, Phillip K.

    1. κ-Opioid Receptor Ligands Inhibit Cocaine-Induced HIV-1 Expression in Microglial Cells
      Genya Gekker, Shuxian Hu, Mark P. Wentland, Jean M. Bidlack, James R. Lokensgard and Phillip K. Peterson
      Journal of Pharmacology and Experimental Therapeutics May 2004, 309 (2) 600-606; DOI: https://doi.org/10.1124/jpet.103.060160

  2. Pettibone, Douglas J.

    1. A Novel Selective Allosteric Modulator Potentiates the Activity of Native Metabotropic Glutamate Receptor Subtype 5 in Rat Forebrain
      Julie A. O'Brien, Wei Lemaire, Marion Wittmann, Marlene A. Jacobson, Sookhee N. Ha, David D. Wisnoski, Craig W. Lindsley, Hervé J. Schaffhauser, Blake Rowe, Cyrille Sur, Mark E. Duggan, Douglas J. Pettibone, P. Jeffrey Conn and David L. Williams
      Journal of Pharmacology and Experimental Therapeutics May 2004, 309 (2) 568-577; DOI: https://doi.org/10.1124/jpet.103.061747

  3. Pirotte, Bernard

    1. Pharmacological Characterization of N-tert-Butyl-N′-[2-(4′-methylphenylamino)-5-nitrobenzenesulfonyl]urea (BM-573), a Novel Thromboxane A2 Receptor Antagonist and Thromboxane Synthase Inhibitor in a Rat Model of Arterial Thrombosis and Its Effects on Bleeding Time
      Jean-Michel Dogné, Julien Hanson, Xavier de Leval, Philippe Kolh, Vincent Tchana-Sato, Laurence de Leval, Stéphanie Rolin, Alexandre Ghuysen, Patrick Segers, Bernard Lambermont, Bernard Masereel and Bernard Pirotte
      Journal of Pharmacology and Experimental Therapeutics May 2004, 309 (2) 498-505; DOI: https://doi.org/10.1124/jpet.103.063610

  4. Planchenault, Claudine

    1. SSR240612 [(2R)-2-[((3R)-3-(1,3-Benzodioxol-5-yl)-3-{[(6-methoxy-2-naphthyl)sulfonyl]amino}propanoyl)amino]-3-(4-{[2R,6S)-2,6-dimethylpiperidinyl]methyl}phenyl)-N-isopropyl-N-methylpropanamide Hydrochloride], a New Nonpeptide Antagonist of the Bradykinin B1 Receptor: Biochemical and Pharmacological Characterization
      Jean Gougat, Bernard Ferrari, Lionel Sarran, Claudine Planchenault, Martine Poncelet, Jeanne Maruani, Richard Alonso, Annie Cudennec, Tiziano Croci, Fabio Guagnini, Katalin Urban-Szabo, Jean-Pierre Martinolle, Philippe Soubrié, Olivier Finance and Gérard Le Fur
      Journal of Pharmacology and Experimental Therapeutics May 2004, 309 (2) 661-669; DOI: https://doi.org/10.1124/jpet.103.059527

  5. Pleiner, Johannes

    1. Specific Endothelin ETA Receptor Antagonism Does Not Modulate Insulin-Induced Hemodynamic Effects in the Human Kidney, Eye, or Forearm
      Anna Rab, Susanne Dallinger, Kaija Polak, Johannes Pleiner, Elzbieta Polska, Michael Wolzt and Leopold Schmetterer
      Journal of Pharmacology and Experimental Therapeutics May 2004, 309 (2) 692-696; DOI: https://doi.org/10.1124/jpet.103.059444

  6. Polak, Kaija

    1. Specific Endothelin ETA Receptor Antagonism Does Not Modulate Insulin-Induced Hemodynamic Effects in the Human Kidney, Eye, or Forearm
      Anna Rab, Susanne Dallinger, Kaija Polak, Johannes Pleiner, Elzbieta Polska, Michael Wolzt and Leopold Schmetterer
      Journal of Pharmacology and Experimental Therapeutics May 2004, 309 (2) 692-696; DOI: https://doi.org/10.1124/jpet.103.059444

  7. Poland, Russell E.

    1. Comparison of the Effects of Dextromethorphan, Dextrorphan, and Levorphanol on the Hypothalamo-Pituitary-Adrenal Axis
      Robert N. Pechnick and Russell E. Poland
      Journal of Pharmacology and Experimental Therapeutics May 2004, 309 (2) 515-522; DOI: https://doi.org/10.1124/jpet.103.060038

  8. Polska, Elzbieta

    1. Specific Endothelin ETA Receptor Antagonism Does Not Modulate Insulin-Induced Hemodynamic Effects in the Human Kidney, Eye, or Forearm
      Anna Rab, Susanne Dallinger, Kaija Polak, Johannes Pleiner, Elzbieta Polska, Michael Wolzt and Leopold Schmetterer
      Journal of Pharmacology and Experimental Therapeutics May 2004, 309 (2) 692-696; DOI: https://doi.org/10.1124/jpet.103.059444

  9. Poncelet, Martine

    1. SSR240612 [(2R)-2-[((3R)-3-(1,3-Benzodioxol-5-yl)-3-{[(6-methoxy-2-naphthyl)sulfonyl]amino}propanoyl)amino]-3-(4-{[2R,6S)-2,6-dimethylpiperidinyl]methyl}phenyl)-N-isopropyl-N-methylpropanamide Hydrochloride], a New Nonpeptide Antagonist of the Bradykinin B1 Receptor: Biochemical and Pharmacological Characterization
      Jean Gougat, Bernard Ferrari, Lionel Sarran, Claudine Planchenault, Martine Poncelet, Jeanne Maruani, Richard Alonso, Annie Cudennec, Tiziano Croci, Fabio Guagnini, Katalin Urban-Szabo, Jean-Pierre Martinolle, Philippe Soubrié, Olivier Finance and Gérard Le Fur
      Journal of Pharmacology and Experimental Therapeutics May 2004, 309 (2) 661-669; DOI: https://doi.org/10.1124/jpet.103.059527

  10. Potter, David E.

    1. Bremazocine Increases C-Type Natriuretic Peptide Levels in Aqueous Humor and Enhances Outflow Facility
      David E. Potter, Karen R. M. Russell and Marlina Manhiani
      Journal of Pharmacology and Experimental Therapeutics May 2004, 309 (2) 548-553; DOI: https://doi.org/10.1124/jpet.103.063107
« Previous (Pages : 19 20 21 22 23 24 25 26 27 28 ... 33) Next »
Back to top

In this issue

Advertisement